Hap Trading, LLC Merck & Co., Inc. Call Options Transaction History

Hap Trading, LLC

$872 Billion
Q3 2024

Call Options

29 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	BUY	$111.15 - $128.97 $22,230 - $25,794	200 Added 1.68%	12,100 $17 Million
Q2 2024 Aug 14, 2024	SELL	$123.8 - $132.96 $37,140 - $39,888	-300 Reduced 2.46%	11,900 $34 Million
Q1 2024 May 13, 2024	BUY	$113.24 - $131.95 $135,888 - $158,340	1,200 Added 10.91%	12,200 $99.8 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $711,278 - $774,042	-7,100 Reduced 39.23%	11,000 $40 Million
Q3 2023 Nov 09, 2023	SELL	$102.95 - $114.33 $10,295 - $11,433	-100 Reduced 0.55%	18,100 $1.86 Million
Q2 2023 Aug 11, 2023	SELL	$108.61 - $118.38 $23.6 Million - $25.8 Million	-217,700 Reduced 92.28%	18,200 $2.1 Million
Q1 2023 May 12, 2023	SELL	$102.94 - $114.86 $452,936 - $505,384	-4,400 Reduced 1.83%	235,900 $2.11 Million
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $19.1 Million - $24.4 Million	218,000 Added 977.58%	240,300 $3.62 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $1.34 Million - $1.51 Million	-15,900 Reduced 41.62%	22,300 $115,000
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $1.5 Million - $1.7 Million	-18,000 Reduced 32.03%	38,200 $228,000
Q1 2022 May 12, 2022	SELL	$73.51 - $82.4 $1.02 Million - $1.15 Million	-13,900 Reduced 19.83%	56,200 $133,000
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $505,960 - $633,780	-7,000 Reduced 9.08%	70,100 $134,000
Q3 2021 Nov 10, 2021	BUY	$71.68 - $78.83 $1.71 Million - $1.88 Million	23,800 Added 44.65%	77,100 $234,000
Q2 2021 Aug 11, 2021	BUY	$70.31 - $77.77 $7,031 - $7,777	100 Added 0.19%	53,300 $159,000
Q1 2021 May 14, 2021	BUY	$68.86 - $81.11 $846,978 - $997,653	12,300 Added 30.07%	53,200 $38,000
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $516,744 - $573,480	7,200 Added 21.36%	40,900 $58,000
Q3 2020 Nov 13, 2020	SELL	$73.18 - $82.95 $1.1 Million - $1.24 Million	-15,000 Reduced 30.8%	33,700 $111,000
Q2 2020 Aug 10, 2020	SELL	$70.42 - $80.13 $105,630 - $120,195	-1,500 Reduced 2.99%	48,700 $150,000
Q1 2020 May 08, 2020	SELL	$63.36 - $87.82 $6.13 Million - $8.5 Million	-96,800 Reduced 65.85%	50,200 $156,000
Q4 2019 Feb 11, 2020	SELL	$77.58 - $87.54 $806,832 - $910,416	-10,400 Reduced 6.61%	147,000 $738,000
Q3 2019 Nov 12, 2019	BUY	$76.08 - $82.93 $3.1 Million - $3.38 Million	40,800 Added 34.99%	157,400 $570,000
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $41,904 - $48,954	600 Added 0.52%	116,600 $452,000
Q1 2019 May 10, 2019	BUY	$69.58 - $79.36 $3.52 Million - $4.02 Million	50,600 Added 77.37%	116,000 $539,000
Q4 2018 Feb 12, 2019	BUY	$65.24 - $75.71 $3.07 Million - $3.56 Million	47,000 Added 255.43%	65,400 $214,000
Q3 2018 Nov 09, 2018	BUY	$57.69 - $67.84 $98,073 - $115,328	1,700 Added 10.18%	18,400 $119,000
Q2 2018 Aug 13, 2018	SELL	$50.83 - $59.72 $2.16 Million - $2.54 Million	-42,500 Reduced 71.79%	16,700 $40,000
Q1 2018 May 11, 2018	SELL	$50.96 - $59.23 $55.6 Million - $64.6 Million	-1,091,100 Reduced 94.85%	59,200 $26,000
Q4 2017 Feb 09, 2018	BUY	$51.62 - $61.64 $39.8 Million - $47.5 Million	770,700 Added 203.03%	1,150,300 $37,000
Q3 2017 Nov 08, 2017	BUY	$58.67 - $63.13 $22.3 Million - $24 Million	379,600	379,600 $410,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

Vanguard Group Inc Valley Forge, PA

250M
Shares

$24.9 Billion
0.52% of portfolio
Black Rock Inc. New York, NY

207M
Shares

$20.7 Billion
0.59% of portfolio
State Street Corp Boston, MA

119M
Shares

$11.9 Billion
0.56% of portfolio
Wellington Management Group LLP Boston, MA

75.8M
Shares

$7.57 Billion
1.55% of portfolio
Geode Capital Management, LLC Boston, MA

59.2M
Shares

$5.91 Billion
0.55% of portfolio

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account